JP2007515402A5 - - Google Patents

Download PDF

Info

Publication number
JP2007515402A5
JP2007515402A5 JP2006541282A JP2006541282A JP2007515402A5 JP 2007515402 A5 JP2007515402 A5 JP 2007515402A5 JP 2006541282 A JP2006541282 A JP 2006541282A JP 2006541282 A JP2006541282 A JP 2006541282A JP 2007515402 A5 JP2007515402 A5 JP 2007515402A5
Authority
JP
Japan
Prior art keywords
isomer
salbutamol
mammal
dystomer
automer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006541282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007515402A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/037966 external-priority patent/WO2005051092A2/en
Publication of JP2007515402A publication Critical patent/JP2007515402A/ja
Publication of JP2007515402A5 publication Critical patent/JP2007515402A5/ja
Pending legal-status Critical Current

Links

JP2006541282A 2003-11-20 2004-11-12 哺乳動物および鳥類の体脂肪および体重の減少方法 Pending JP2007515402A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52437603P 2003-11-20 2003-11-20
PCT/US2004/037966 WO2005051092A2 (en) 2003-11-20 2004-11-12 Method of decreasing fat deposits and body weight in mammals and birds
US10/987,665 US20050113456A1 (en) 2003-11-20 2004-11-12 Method of decreasing fat deposits and body weight in mammals and birds

Publications (2)

Publication Number Publication Date
JP2007515402A JP2007515402A (ja) 2007-06-14
JP2007515402A5 true JP2007515402A5 (enExample) 2007-07-26

Family

ID=34595131

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006541282A Pending JP2007515402A (ja) 2003-11-20 2004-11-12 哺乳動物および鳥類の体脂肪および体重の減少方法

Country Status (8)

Country Link
US (2) US20050113456A1 (enExample)
EP (1) EP1684593A4 (enExample)
JP (1) JP2007515402A (enExample)
AU (1) AU2004292416B2 (enExample)
CA (1) CA2545559A1 (enExample)
NZ (1) NZ547178A (enExample)
WO (1) WO2005051092A2 (enExample)
ZA (1) ZA200604077B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2384641T3 (es) 2005-07-14 2012-07-10 Lithera, Inc. Formulación lipolítica que potencia la liberación mantenida para el tratamiento localizado del tejido adiposo
US20070264313A1 (en) * 2006-05-12 2007-11-15 Musser Robert E Methods and compositions relating to animal dietary acids
AU2007313077B2 (en) * 2006-10-17 2011-06-02 Neothetics, Inc. Methods, compositions, and formulations for the treatment of thyroid eye disease
AU2008331928B2 (en) 2007-12-03 2012-08-16 Bridge Pharma, Inc. Use of RR/SR-ractopamine
MY159212A (en) 2008-09-02 2016-12-30 Nutricia Nv Nutritional compositions with coated lipid globules
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
MX2012008171A (es) * 2010-01-15 2012-12-17 Lithera Inc Formulaciones aglomeradas liofilizadas.
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
EP2646012A4 (en) 2010-11-24 2014-12-10 Neothetics Inc MONOTHERAPEUTIC FORMULATIONS OF SELECTIVE, LIPOPHILIC AND PROLONGED BETA AGONISTS AND METHODS OF COSMETIC TREATMENT OF SILHOUETTE ADPOSITY AND REINFORCEMENT
BR112016009351B1 (pt) 2013-11-01 2020-12-22 N.V. Nutricia Uso de lipídio para a preparação de uma composição nutricional e fórmula para recémnascidos
KR102273533B1 (ko) * 2015-06-15 2021-07-06 삼성전자 주식회사 무선 통신 시스템에서 서비스 제공 방법 및 장치
PL3574771T3 (pl) 2015-10-15 2023-03-13 N.V. Nutricia Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu
MY196605A (en) 2016-12-09 2023-04-20 Nutricia Nv Nutritional Composition for Improving Cell Membranes

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085514A3 (en) * 1982-01-28 1984-02-29 Beecham Group Plc Compositions comprising a beta-antagonist and a beta-agonist, their preparation, and their use in treating obese humans and animals
GB8604134D0 (en) * 1986-02-19 1986-03-26 Glaxo Group Ltd Veterinary preparations
US5147869A (en) * 1986-12-11 1992-09-15 Roussel Uclaf Zootechnical compositions
IE60964B1 (en) * 1986-12-11 1994-09-07 Roussel Uclaf Zootechnical compositions containing a beta-adrenergic
US5541188A (en) * 1987-09-15 1996-07-30 The Rowett Research Institute Therapeutic applications of beta-adrenergic agonists
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
FR2642075B1 (fr) * 1989-01-25 1991-04-26 Pasteur Institut Polypeptides ayant une activite de recepteur (beta)-adrenergique chez l'homme, impliques dans la reponse lipolytique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substance active sur ces polypeptides
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
US5362755A (en) * 1990-01-05 1994-11-08 Sepracor, Inc. Method for treating asthma using optically pure (R)-albuterol
WO1991009596A1 (en) * 1990-01-05 1991-07-11 Sepracor, Inc. Optically pure r(-) albuterol for treating asthma
JP3358631B2 (ja) * 1993-05-17 2002-12-24 三菱瓦斯化学株式会社 メタノ−ルの脱水素方法
US5545745A (en) * 1994-05-23 1996-08-13 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
US5399765A (en) * 1994-05-23 1995-03-21 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
US5698199A (en) * 1995-03-10 1997-12-16 Kao Corporation Lipolysis acceleration method
US5708036A (en) * 1996-01-29 1998-01-13 Pesterfield, Jr.; E. Charles Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol
AU737608B2 (en) * 1997-04-30 2001-08-23 Courage Corporation Pty Ltd Composition and methods using an eutomer
US7767708B2 (en) * 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
US6683115B2 (en) * 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
GB0030171D0 (en) * 2000-12-11 2001-01-24 Cipla Ltd Process for preparing isomers of salbutamol

Similar Documents

Publication Publication Date Title
RU2000131222A (ru) Новые аналоги жирных кислот для лечения ожирения, гипертензии и жировой инфильтрации печени
US20080020019A1 (en) Method of decreasing fat deposits and body weight in mammals and birds
JPH04230624A (ja) 犬の加齢による認知機能障害を治療する方法
JP6336592B2 (ja) ヒスタミンh4受容体を介してもたらされた掻痒状態を治療するための医薬組成物
CN1323161A (zh) 防治跳蚤的虱螨脲和烯淀虫胺口服组合物
JP2001031566A (ja) ペットの問題行動抑制組成物
CA2286913C (en) Composition and methods using an eutomer
US12240920B2 (en) Cyclic peptidomimetic for the treatment of neurological disorders
CN1474691A (zh) 联合的5-ht1a激动剂和5-羟色胺再摄取抑制剂的新用途
JP6209208B2 (ja) ブロイラー鶏の性能向上法
JP4629964B2 (ja) ウシの消化器疾患治療剤
US20080070990A1 (en) Use of ractopamine enantiomers
AU691975B2 (en) Use of selegiline to prolong life span
RU2005120958A (ru) Способ профилактики и лечения желудочно-кишечных заболеваний у животных и птиц
JP2004091475A (ja) 高遊離脂肪酸血症の予防または改善用組成物
JPH11222429A (ja) 動物の外部寄生虫の防除方法
RU2024119390A (ru) Применение аминопиразольных соединений
HK1060697B (en) Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
Kyriakis et al. Anorexia-like wasting syndromes in pigs
CN1882320A (zh) 减少哺乳动物和鸟类的脂肪堆积物和体重的方法
JP2004513915A (ja) 複合的な選択的ドーパミンd2レセプターアンタゴニストおよび5−ht1aレセプターアゴニストの新規な使用
HK1060698A (en) Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
EP1787529A2 (en) Composition and methods using an eutomer